First-Progesterone VGS — Highmark
supplement progesterone in infertility and corpus luteum insufficiency as part of an ART treatment program
Initial criteria
- The member is female AND is using the product for one (1) of the following:
- a. Treatment of infertility or prevention of early pregnancy failure (e.g., miscarriage) in females with corpus luteum insufficiency.
- b. To supplement progesterone in females with infertility and corpus luteum insufficiency as part of an ART treatment program.
- c. Prophylaxis for preterm delivery.
Approval duration
6 months for infertility (including hypogonadotropic hypogonadism)